HK1209324A1 - 納米酶、製備納米酶的方法、以及使用納米酶的方法 - Google Patents

納米酶、製備納米酶的方法、以及使用納米酶的方法

Info

Publication number
HK1209324A1
HK1209324A1 HK15110018.0A HK15110018A HK1209324A1 HK 1209324 A1 HK1209324 A1 HK 1209324A1 HK 15110018 A HK15110018 A HK 15110018A HK 1209324 A1 HK1209324 A1 HK 1209324A1
Authority
HK
Hong Kong
Prior art keywords
nanozymes
methods
making
making nanozymes
Prior art date
Application number
HK15110018.0A
Other languages
English (en)
Inventor
雲偉‧查爾斯‧曹
辰‧劉
Original Assignee
Univ Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Florida filed Critical Univ Florida
Publication of HK1209324A1 publication Critical patent/HK1209324A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/08—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
    • C12N11/082—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/14—Enzymes or microbial cells immobilised on or in an inorganic carrier
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
    • A61K47/6923—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being an inorganic particle, e.g. ceramic particles, silica particles, ferrite or synsorb
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5115—Inorganic compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/08—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
    • C12N11/089—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/08—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
    • C12N11/089—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • C12N11/096—Polyesters; Polyamides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Ceramic Engineering (AREA)
  • Physics & Mathematics (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK15110018.0A 2013-08-14 2015-10-14 納米酶、製備納米酶的方法、以及使用納米酶的方法 HK1209324A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361865650P 2013-08-14 2013-08-14
PCT/US2014/050803 WO2015023715A1 (en) 2013-08-14 2014-08-13 Nanozymes, methods of making nanozymes, and methods of using nanozymes

Publications (1)

Publication Number Publication Date
HK1209324A1 true HK1209324A1 (zh) 2016-04-01

Family

ID=52468646

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15110018.0A HK1209324A1 (zh) 2013-08-14 2015-10-14 納米酶、製備納米酶的方法、以及使用納米酶的方法

Country Status (5)

Country Link
US (1) US10538757B2 (zh)
CN (1) CN104519875A (zh)
HK (1) HK1209324A1 (zh)
TW (1) TW201521762A (zh)
WO (1) WO2015023715A1 (zh)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6507969B2 (ja) * 2015-09-25 2019-05-08 コニカミノルタ株式会社 ガス検知方法及びガス検知装置
EP3370518B1 (en) 2015-10-14 2023-08-23 X-Therma, Inc. Compositions and methods for reducing ice crystal formation
CN106011125B (zh) * 2016-06-08 2022-02-15 吉林大学 一种过氧化物纳米酶及其制备方法
CN108067309B (zh) * 2016-11-14 2020-02-04 中国科学院生物物理研究所 优化纳米酶颗粒活性的方法
CN107338291A (zh) * 2017-06-22 2017-11-10 中国农业大学 基于核酸层析生物传感技术检测大肠杆菌o157的方法
CN108287134B (zh) * 2017-12-28 2020-11-24 南京邮电大学 单颗粒生物探针及其等离子体生物存储器的构建方法
CN108982834B (zh) * 2018-04-28 2021-04-23 公安部物证鉴定中心 纳米酶免疫夹心新技术检测生物分子的方法
WO2020018739A1 (en) * 2018-07-18 2020-01-23 University Of Florida Research Foundation Rna silencing nanozymes
CN109364272B (zh) * 2018-11-30 2021-08-20 中国科学院生物物理研究所 纳米酶小体在催化光声成像中的应用
CN109799313B (zh) * 2019-01-11 2021-07-27 南京大学 基于核酸碱基或其衍生物的氮掺杂碳材料纳米酶及其制备方法和应用
CN113975459B (zh) * 2021-12-13 2022-10-25 昆明理工大学 一种纳米酶水凝胶片的制备方法及在创可贴中的应用
CN115154482B (zh) * 2022-01-14 2023-05-02 河北金益合生物技术有限公司 硫化铁纳米酶抗人***瘤病毒的用途
CN114621924B (zh) * 2022-04-03 2024-05-17 中国科学院长春应用化学研究所 一种多孔碳球纳米酶掺杂的氢键有机框架壳层及其制备方法
WO2024020366A1 (en) * 2022-07-18 2024-01-25 University Of Florida Research Foundation, Inc. Broad spectrum nanozymes

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6582921B2 (en) 1996-07-29 2003-06-24 Nanosphere, Inc. Nanoparticles having oligonucleotides attached thereto and uses thereof
ATE228883T1 (de) * 1998-03-19 2002-12-15 Max Planck Gesellschaft Herstellung von mit mehrlagen gestrichenen partikeln und hohlen schalen durch elektrostatische selbstorganisierung von nanokompositmehrlagen auf zersetzbaren schablonen
US7101575B2 (en) * 1998-03-19 2006-09-05 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Production of nanocapsules and microcapsules by layer-wise polyelectrolyte self-assembly
KR19990085365A (ko) 1998-05-16 1999-12-06 허영섭 지속적으로 약물 조절방출이 가능한 생분해성 고분자 미립구 및그 제조방법
JP3759341B2 (ja) 1999-07-19 2006-03-22 東芝テック株式会社 ラインサーマルプリンタ
GB0025414D0 (en) 2000-10-16 2000-11-29 Consejo Superior Investigacion Nanoparticles
GB2410687A (en) 2002-11-20 2005-08-10 Univ Bar Ilan Biological glue based on thrombin-conjugated nanoparticles
WO2005044224A2 (en) * 2003-05-02 2005-05-19 Case Western Reserve University Drug delivery system based on polymer nanoshells
WO2005002714A2 (en) * 2003-06-03 2005-01-13 William Marsh Rice University Supported catalysts using nanoparticles as the support material
US7727969B2 (en) 2003-06-06 2010-06-01 Massachusetts Institute Of Technology Controlled release nanoparticle having bound oligonucleotide for targeted delivery
CA2567741A1 (en) 2004-05-25 2006-03-30 Chimeracore, Inc. Self-assembling nanoparticle drug delivery system
WO2006044716A2 (en) 2004-10-15 2006-04-27 Washington University In St.Louis CELL PERMEABLE NANOCONJUGATES OF SHELL-CROSSLINKED KNEDEL (SCK) AND PEPTIDE NUCLEIC ACIDS ('PNAs') WITH UNIQUELY EXPRESSED OR OVER-EXPRESSED mRNA TARGETING SEQUENCES FOR EARLY DIAGNOSIS AND THERAPY OF CANCER
US7829140B1 (en) * 2006-03-29 2010-11-09 The Research Foundation Of The State University Of New York Method of forming iron oxide core metal shell nanoparticles
JP5145554B2 (ja) 2006-03-31 2013-02-20 国立大学法人東京農工大学 アプタマー・導電性粒子複合体、アプタマー・導電性粒子・プローブ複合体、および指示タンパク質の特性を制御する方法
EP2007435B1 (en) 2006-03-31 2019-12-18 Massachusetts Institute Of Technology System for targeted delivery of therapeutic agents
EP1847600A1 (en) 2006-04-18 2007-10-24 Direvo Biotech AG Specific protease for inactivation of human tumour necrosis factor-alpha
US8323694B2 (en) 2007-05-09 2012-12-04 Nanoprobes, Inc. Gold nanoparticles for selective IR heating
US8563527B2 (en) 2007-08-20 2013-10-22 Pharmain Corporation Oligonucleotide core carrier compositions for delivery of nucleic acid-containing therapeutic agents, methods of making and using the same
ITFI20070285A1 (it) * 2007-12-19 2009-06-20 Colorobbia Italiana Spa Nanosfere con superficie esterna in metalli nobili.
WO2010009087A1 (en) 2008-07-15 2010-01-21 Eyegate Pharmaceuticals, Inc. Iontophoretic delivery of a controlled-release formulation in the eye
WO2010014895A2 (en) 2008-07-31 2010-02-04 Enzon Pharmaceuticals, Inc. Nanoparticle compositions for nucleic acids delivery system
US20100092470A1 (en) 2008-09-22 2010-04-15 Icb International, Inc. Antibodies, analogs and uses thereof
WO2010117957A2 (en) 2009-04-06 2010-10-14 Mayo Foundation For Medical Education And Research Methods and materials for delivering molecules
JP2013524811A (ja) * 2010-04-20 2013-06-20 ユニバーシティ オブ フロリダ リサーチ ファンデーション インコーポレーティッド ナノザイム、ナノザイムの製造方法、およびナノザイムの使用方法

Also Published As

Publication number Publication date
WO2015023715A1 (en) 2015-02-19
US20160215279A1 (en) 2016-07-28
CN104519875A (zh) 2015-04-15
TW201521762A (zh) 2015-06-16
US10538757B2 (en) 2020-01-21

Similar Documents

Publication Publication Date Title
HRP20170888T1 (hr) Spoj tubulisina, metode pripreme i primjena
GB2535360B (en) Methods of preparing polyhemiaminals and polyhexahydrotriazines
HK1209324A1 (zh) 納米酶、製備納米酶的方法、以及使用納米酶的方法
AU355178S (en) Earring
AU353527S (en) Earring
IL269622A (en) Preparation of (s,s)-secoisolariciresinol diglucoside and (r,r)- secoisolariciresinol diglucoside
EP3000133A4 (en) SENSORS, METHOD OF MANUFACTURING AND DEVICES
HK1224307A1 (zh) 原毒素- 變體及其使用方法
GB201312318D0 (en) Novel methods and compounds
EP2988764A4 (en) COMPOSITIONS AGAINST DANDRUFF AND METHOD FOR USE THEREOF
GB201306980D0 (en) Methods
EP2971531A4 (en) SHOVELS AND MANUFACTURING PROCESS
HK1223111A1 (zh) 方法
GB201312444D0 (en) Methods
GB201308516D0 (en) Methods
ZA201600015B (en) Anti-fibrogenic compounds, methods and uses thereof
EP2870133A4 (en) TETRAHYDRO ISOHUMULOD DERIVATIVES, METHOD FOR THE PREPARATION AND USE THEREOF
GB201304234D0 (en) Methods
GB201311696D0 (en) Assembly and methods
HK1218781A1 (zh) 方法
GB2519994B (en) Assemblies and methods
EP2970175A4 (en) CELLULAR ADDUCTS, METHODS OF MAKING SAME, AND USES THEREOF
GB201322740D0 (en) Methods
GB201319245D0 (en) Methods
GB201304166D0 (en) CelebQuiff and Instant Quiff